{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:10:42Z","timestamp":1786975842977,"version":"build-2736575974"},"reference-count":74,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1001\/jamapsychiatry.2018.3421","type":"journal-article","created":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T11:33:21Z","timestamp":1544614401000},"page":"162","source":"Crossref","is-referenced-by-count":92,"title":["Association of Antipsychotic Treatment With Risk of Unexpected Death Among Children and Youths"],"prefix":"10.1001","volume":"76","author":[{"given":"Wayne A.","family":"Ray","sequence":"first","affiliation":[{"name":"Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Michael","family":"Stein","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee"},{"name":"Division of Clinical Pharmacology, Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine T.","family":"Murray","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee"},{"name":"Division of Cardiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Catherine","family":"Fuchs","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Science, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Patrick","sequence":"additional","affiliation":[{"name":"Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee"},{"name":"Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee"},{"name":"Vanderbilt Center for Child Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Daugherty","sequence":"additional","affiliation":[{"name":"Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathi","family":"Hall","sequence":"additional","affiliation":[{"name":"Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William O.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee"},{"name":"Vanderbilt Center for Child Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"yoi180084r1","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1001\/archpedi.158.8.753","article-title":"New users of antipsychotic medications among children enrolled in TennCare.","volume":"158","author":"Cooper","year":"2004","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"2","key":"yoi180084r2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ambp.2005.11.002","article-title":"Trends in prescribing of antipsychotic medications for US children.","volume":"6","author":"Cooper","year":"2006","journal-title":"Ambul Pediatr"},{"issue":"12","key":"yoi180084r3","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1001\/archgenpsychiatry.2012.647","article-title":"National trends in the office-based treatment of children, adolescents, and adults with antipsychotics.","volume":"69","author":"Olfson","year":"2012","journal-title":"Arch Gen Psychiatry"},{"issue":"9","key":"yoi180084r4","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1001\/jamapsychiatry.2015.0500","article-title":"Treatment of young people with antipsychotic medications in the United States.","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"yoi180084r5","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1001\/jamapsychiatry.2015.0632","article-title":"Antipsychotic use in youth without psychosis: a double-edged sword.","volume":"72","author":"Correll","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"yoi180084r6","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1001\/archpsyc.58.12.1161","article-title":"Antipsychotics and the risk of sudden cardiac death.","volume":"58","author":"Ray","year":"2001","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"yoi180084r7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical antipsychotic drugs and the risk of sudden cardiac death.","volume":"360","author":"Ray","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"yoi180084r8","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/sj.npp.1301492","article-title":"ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia.","volume":"33","author":"Jeste","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"yoi180084r9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaac.2014.10.002","article-title":"Corrected QT changes during antipsychotic treatment of children and adolescents: a systematic review and meta-analysis of clinical trials.","volume":"54","author":"Jensen","year":"2015","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"yoi180084r10","first-page":"130","article-title":"Acute oxcarbazepine and atomoxetine overdose with quetiapine.","volume":"46","author":"Barker","year":"2004","journal-title":"Vet Hum Toxicol"},{"issue":"6","key":"yoi180084r11","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1345\/aph.1L170","article-title":"Inadvertent administration of intravenous ziprasidone leading to bradycardia and QT interval prolongation.","volume":"42","author":"Bentley","year":"2008","journal-title":"Ann Pharmacother"},{"issue":"1","key":"yoi180084r12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1081\/CLT-120018276","article-title":"Cardiotoxicity associated with intentional ziprasidone and bupropion overdose.","volume":"41","author":"Biswas","year":"2003","journal-title":"J Toxicol Clin Toxicol"},{"issue":"1","key":"yoi180084r13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0033-3182(00)71175-3","article-title":"QT interval prolongation associated with quetiapine (Seroquel) overdose.","volume":"41","author":"Gajwani","year":"2000","journal-title":"Psychosomatics"},{"issue":"7","key":"yoi180084r14","doi-asserted-by":"crossref","first-page":"354","DOI":"10.5694\/j.1326-5377.2006.tb00272.x","article-title":"Amisulpride deliberate self-poisoning causing severe cardiac toxicity including QT prolongation and torsades de pointes.","volume":"184","author":"Isbister","year":"2006","journal-title":"Med J Aust"},{"issue":"4","key":"yoi180084r15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/10401230490522061","article-title":"Pediatric case report of quetiapine overdose and QTc prolongation.","volume":"16","author":"Kurth","year":"2004","journal-title":"Ann Clin Psychiatry"},{"issue":"4","key":"yoi180084r16","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jemermed.2013.04.033","article-title":"Cardiotoxicity in a citalopram and olanzapine overdose.","volume":"45","author":"Lung","year":"2013","journal-title":"J Emerg Med"},{"issue":"4","key":"yoi180084r17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1089\/cap.1999.9.273","article-title":"Risperidone in the treatment of two very young children with autism.","volume":"9","author":"Posey","year":"1999","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1","key":"yoi180084r18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00787-008-0699-3","article-title":"QTc prolongation associated with atypical antipsychotic use in the treatment of adolescent-onset anorexia nervosa.","volume":"18","author":"Ritchie","year":"2009","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"issue":"9","key":"yoi180084r19","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00787-013-0413-y","article-title":"Mandatory electrocardiographic monitoring in young patients treated with psychoactive drugs.","volume":"22","author":"Rizzo","year":"2013","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"10","key":"yoi180084r20","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1001\/jamapsychiatry.2013.2053","article-title":"Antipsychotics and the risk of type 2 diabetes mellitus in children and youth.","volume":"70","author":"Bobo","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"yoi180084r21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1001\/jamapsychiatry.2015.2923","article-title":"Type 2 diabetes mellitus in youth exposed to antipsychotics: a systematic review and meta-analysis.","volume":"73","author":"Galling","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"yoi180084r22","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1089\/cap.2004.14.612","article-title":"Olanzapine-induced diabetes in a seven-year-old boy.","volume":"14","author":"Courvoisie","year":"2004","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1","key":"yoi180084r23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000104222","article-title":"Pancreatitis following olanzapine therapy: a report of three cases.","volume":"1","author":"Kerr","year":"2007","journal-title":"Case Rep Gastroenterol"},{"issue":"2","key":"yoi180084r24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/JCP.0000000000000459","article-title":"Acute pancreatitis associated with antipsychotic medication: evaluation of clinical features, treatment, and polypharmacy in a series of cases.","volume":"36","author":"Silva","year":"2016","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"yoi180084r25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/jcpt.2013.38.issue-2","article-title":"Accidental clozapine intoxication in a toddler: clinical and pharmacokinetic lessons learnt.","volume":"38","author":"Toepfner","year":"2013","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"yoi180084r26","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1089\/104454601317261609","article-title":"Atypical antipsychotic overdose in the pediatric population.","volume":"11","author":"Catalano","year":"2001","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"yoi180084r27","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/PEC.0b013e31819e3775","article-title":"Pediatric ziprasidone overdose.","volume":"25","author":"Fasano","year":"2009","journal-title":"Pediatr Emerg Care"},{"issue":"3","key":"yoi180084r28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1055\/s-2008-1058111","article-title":"Respiratory dysfunction in sleep apnea associated with quetiapine.","volume":"41","author":"Freudenmann","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"yoi180084r29","doi-asserted-by":"crossref","DOI":"10.1007\/s11325-017-1537-y","article-title":"A weight-independent association between atypical antipsychotic medications and obstructive sleep apnea.","author":"Khazaie","year":"2018","journal-title":"Sleep Breath"},{"issue":"3","key":"yoi180084r30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1055\/s-0029-1242822","article-title":"Acute respiratory distress due to antipsychotic drugs.","volume":"43","author":"Yagmur","year":"2010","journal-title":"Pharmacopsychiatry"},{"key":"yoi180084r31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4088\/JCP.v60n0102","article-title":"Receptor pharmacology of neuroleptics: relation to clinical effects.","volume":"60","author":"Richelson","year":"1999","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"yoi180084r32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/schbul\/19.2.303","article-title":"Tardive dyskinesia.","volume":"19","author":"Jeste","year":"1993","journal-title":"Schizophr Bull"},{"issue":"12","key":"yoi180084r33","doi-asserted-by":"publisher","first-page":"927","DOI":"10.2165\/00128072-200103120-00005","article-title":"Tolerability profile of atypical antipsychotics in children and adolescents.","volume":"3","author":"Stigler","year":"2001","journal-title":"Paediatr Drugs"},{"issue":"4","key":"yoi180084r34","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1176\/appi.ajp.161.4.700","article-title":"Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits.","volume":"161","author":"Centorrino","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"12","key":"yoi180084r35","doi-asserted-by":"publisher","first-page":"967","DOI":"10.4088\/JCP.v62n1209","article-title":"Neuroleptic-related dyskinesias in children and adolescents.","volume":"62","author":"Connor","year":"2001","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"yoi180084r36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1684\/epd.2016.0805","article-title":"Olanzapine-related repetitive focal seizures with lingual dystonia.","volume":"18","author":"Anzellotti","year":"2016","journal-title":"Epileptic Disord"},{"issue":"9-10","key":"yoi180084r37","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2298\/SARH1310667M","article-title":"Chlorpromazine-induced status epilepticus: a case report.","volume":"141","author":"Momcilovic-Kostadinovic","year":"2013","journal-title":"Srp Arh Celok Lek"},{"issue":"1","key":"yoi180084r38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/WNF.0b013e3182767efb","article-title":"Aripiprazole-induced seizure in a 3-year-old child: a case report and literature review.","volume":"36","author":"Thabet","year":"2013","journal-title":"Clin Neuropharmacol"},{"issue":"4","key":"yoi180084r39","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1089\/cap.2016.0180","article-title":"Neuroleptic malignant syndrome\/malignant catatonia in child psychiatry: literature review and a case series.","volume":"27","author":"Ghaziuddin","year":"2017","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"yoi180084r40","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/oxfordjournals.aje.a115198","article-title":"Use of Medicaid data for pharmacoepidemiology.","volume":"129","author":"Ray","year":"1989","journal-title":"Am J Epidemiol"},{"issue":"3","key":"yoi180084r41","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/oxfordjournals.aje.a115692","article-title":"Methodological issues in evaluating expanded Medicaid coverage for pregnant women.","volume":"132","author":"Piper","year":"1990","journal-title":"Am J Epidemiol"},{"issue":"17","key":"yoi180084r43","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1056\/NEJMp038145","article-title":"Population-based studies of adverse drug effects.","volume":"349","author":"Ray","year":"2003","journal-title":"N Engl J Med"},{"issue":"5","key":"yoi180084r44","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/geront\/28.5.672","article-title":"Validation of two methods of data collection of self-reported medicine use among the elderly.","volume":"28","author":"Landry","year":"1988","journal-title":"Gerontologist"},{"issue":"11","key":"yoi180084r45","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/jgs.1991.39.issue-11","article-title":"Comparing sources of drug data about the elderly.","volume":"39","author":"Johnson","year":"1991","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"yoi180084r46","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1093\/oxfordjournals.aje.a117563","article-title":"Recall accuracy for prescription medications: self-report compared with database information.","volume":"142","author":"West","year":"1995","journal-title":"Am J Epidemiol"},{"key":"yoi180084r47","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.jad.2009.06.041","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy.","volume":"117","author":"Lam","year":"2009","journal-title":"J Affect Disord"},{"issue":"4","key":"yoi180084r48","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.genhosppsych.2007.04.001","article-title":"A qualitative exploration of depression in emerging adulthood: disorder, development, and social context.","volume":"29","author":"Kuwabara","year":"2007","journal-title":"Gen Hosp Psychiatry"},{"issue":"23","key":"yoi180084r49","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1056\/NEJMp078015","article-title":"Expanding the black box\u2013depression, antidepressants, and the risk of suicide.","volume":"356","author":"Friedman","year":"2007","journal-title":"N Engl J Med"},{"issue":"20","key":"yoi180084r50","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1056\/NEJMoa1110212","article-title":"ADHD drugs and serious cardiovascular events in children and young adults.","volume":"365","author":"Cooper","year":"2011","journal-title":"N Engl J Med"},{"issue":"9","key":"yoi180084r52","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs.","volume":"158","author":"Ray","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"1","key":"yoi180084r53","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/pds.v24.1","article-title":"Performance of time-dependent propensity scores: a pharmacoepidemiology case study.","volume":"24","author":"Ray","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"yoi180084r54","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s10803-012-1723-5","article-title":"Risperidone dosing in children and adolescents with autistic disorder: a double-blind, placebo-controlled study.","volume":"43","author":"Kent","year":"2013","journal-title":"J Autism Dev Disord"},{"key":"yoi180084r55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4088\/PCC.v06n0101","article-title":"Atypical antipsychotics: sleep, sedation, and efficacy.","volume":"6","author":"Miller","year":"2004","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"3","key":"yoi180084r56","doi-asserted-by":"publisher","first-page":"e20162757","DOI":"10.1542\/peds.2016-2757","article-title":"The Sudden Death in the Young Case Registry: collaborating to understand and reduce mortality.","volume":"139","author":"Burns","year":"2017","journal-title":"Pediatrics"},{"issue":"1","key":"yoi180084r57","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1053\/j.nainr.2009.12.010","article-title":"A primer on propensity score analysis.","volume":"10","author":"Shadish","year":"2010","journal-title":"Newborn Infant Nurs Rev"},{"issue":"3","key":"yoi180084r58","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding on observational studies.","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"15","key":"yoi180084r59","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1001\/jama.2015.13480","article-title":"The Propensity Score.","volume":"314","author":"Haukoos","year":"2015","journal-title":"JAMA"},{"issue":"2","key":"yoi180084r60","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s40264-016-0480-3","article-title":"Propensity score weighting compared to matching in a study of dabigatran and warfarin.","volume":"40","author":"Seeger","year":"2017","journal-title":"Drug Saf"},{"issue":"10","key":"yoi180084r61","doi-asserted-by":"publisher","first-page":"735","DOI":"10.7326\/0003-4819-158-10-201305210-00008","article-title":"Trends in reporting methadone-associated cardiac arrhythmia, 1997-2011: an analysis of registry data.","volume":"158","author":"Kao","year":"2013","journal-title":"Ann Intern Med"},{"issue":"9","key":"yoi180084r62","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2146\/ajhp070392","article-title":"Methadone-associated Q-T interval prolongation and torsades de pointes.","volume":"66","author":"Stringer","year":"2009","journal-title":"Am J Health Syst Pharm"},{"issue":"RR-22","key":"yoi180084r63","first-page":"1","article-title":"School health guidelines to prevent unintentional injuries and violence.","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Recomm Rep"},{"key":"yoi180084r64","first-page":"270","article-title":"Vital signs: unintentional injury deaths among persons aged 0-19 years\u2014United States, 2000-2009.","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"yoi180084r65","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1001\/jamapsychiatry.2018.1080","article-title":"The urgent need for optimal monitoring of metabolic adverse effects in children and youngsters who take on-label or off-label antipsychotic medication.","volume":"75","author":"De Hert","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"yoi180084r66","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/chi.0b013e31815b5cb1","article-title":"Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes.","volume":"47","author":"Correll","year":"2008","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"8","key":"yoi180084r67","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jamapsychiatry.2018.1088","article-title":"Metabolic effects of antipsychotics on adiposity and insulin sensitivity in youths: a randomized clinical trial.","volume":"75","author":"Nicol","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"yoi180084r68","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.2337\/dc08-0441","article-title":"Diabetic ketoacidosis induced by aripiprazole in a 12-year-old boy.","volume":"31","author":"Dhamija","year":"2008","journal-title":"Diabetes Care"},{"issue":"12","key":"yoi180084r69","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1001\/jama.2011.1360","article-title":"Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis.","volume":"306","author":"Maher","year":"2011","journal-title":"JAMA"},{"issue":"18","key":"yoi180084r70","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1007\/s00213-015-4024-9","article-title":"The cardiac safety of aripiprazole treatment in patients at high risk for torsade: a systematic review with a meta-analytic approach.","volume":"232","author":"Polcwiartek","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"yoi180084r71","doi-asserted-by":"publisher","first-page":"e150285","DOI":"10.1001\/jamapediatrics.2015.0285","article-title":"Risk for incident diabetes mellitus following initiation of second-generation antipsychotics among Medicaid-enrolled youths.","volume":"169","author":"Rubin","year":"2015","journal-title":"JAMA Pediatr"},{"issue":"2","key":"yoi180084r72","doi-asserted-by":"publisher","first-page":"135","DOI":"10.7150\/ijms.10453","article-title":"Antipsychotics-associated serious adverse events in children: an analysis of the FAERS database.","volume":"12","author":"Kimura","year":"2015","journal-title":"Int J Med Sci"},{"issue":"1","key":"yoi180084r74","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaac.2016.10.005","article-title":"Trends in antipsychotic prescribing in Medicaid-eligible youth.","volume":"56","author":"Edelsohn","year":"2017","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"yoi180084r42","unstructured":"TN Department of Health. Hospital Discharge Data System. https:\/\/www.tn.gov\/health\/health-program-areas\/statistics\/special-reports\/hdds.html. Accessed October 29, 2018."},{"key":"yoi180084r51","unstructured":"US Food and Drug Administration. Providing Information about Pediatric Uses of Medical Devices - Guidance for Industry and Food and Drug Administration Staff. 2014; https:\/\/www.fda.gov\/RegulatoryInformation\/Guidances\/ucm082185.htm."},{"key":"yoi180084r73","unstructured":"HenryJ. Kaiser Family Foundation. Health Insurance Coverage of Children 0-18: 2015https:\/\/www.kff.org\/other\/state-indicator\/children-0-18\/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D. Accessed October 29, 2018."}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2717966","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T07:15:04Z","timestamp":1605597304000},"score":1,"resource":{"primary":{"URL":"http:\/\/archpsyc.jamanetwork.com\/article.aspx?doi=10.1001\/jamapsychiatry.2018.3421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2018.3421","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2,1]]}}}